Adverum Biotechnologies, Inc.

Ownership Transactions Reported by 26 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+913K	98.6%	$3.94	+$3.6M
Sells	3	-13K	1.4%	$2.00	-$26K
Net	-2	+900K	97.2%		+$3.57M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Braden Michael Leonard	10%+ Owner	$12.6M	+$3.6M	+39.9%	Apr 22, 2025
Julie Clark	Chief Medical Officer	$255K			Sep 30, 2021
Angela Thedinga	Chief Technology Officer	$232K			Aug 6, 2021
Brigit Riley	Chief Scientific Officer	$182K			Mar 15, 2023
Laurent Fischer	CEO, PRESIDENT AND DIRECTOR, Director	$175K	-$18.3K	-9.45%	Jun 17, 2025
Linda M. Rubinstein	Chief Financial Officer	$138K			Jun 17, 2025
John Rakow	SVP, Genl Counsel, Acting CFO	$90.2K			Sep 14, 2022
Peter Soparkar	Chief Operating Officer	$78.3K	-$5.92K	-7.03%	Jun 17, 2025
Richard Beckman	Chief Medical Officer	$60.5K			Mar 1, 2023
Rabia Gurses Ozden	Chief Medical Officer	$58.1K			Jun 17, 2025
Rupert D'Souza	Chief Financial Officer	$32.3K			May 13, 2022
Setareh Seyedkazemi	Chief Development Officer	$27.5K	-$1.85K	-6.29%	Jun 17, 2025
Nancy Pecota	Principal Accounting Officer				Jun 6, 2022
Mehdi Gasmi	Director				May 12, 2021
Soo Hong	Director				Jun 17, 2025
Thomas Woiwode	Director				May 12, 2021
Patrick Machado	Director				Jun 17, 2025
Mark Lupher Jr.	Director				Jun 17, 2025
James Scopa	Director				Jun 17, 2025
Reed Vaughn Tuckson	Director				Jun 17, 2025
C. David Nicholson	Director				Jun 17, 2025
Scott M. Whitcup	Director				Jun 17, 2025
Christopher DeRespino	Acting Chief Financial Officer and Chief Business Officer				Jun 24, 2021
Jack Anthony Thrift	Interim CFO				Sep 2, 2021
Szilard Kiss	Director				Jun 17, 2025
Dawn Svoronos	Director				Jun 17, 2025

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.